Theravance Biopharma, Inc. (TBPH)
CYM
Total Compensation for Fiscal Year Ending in 2022: $6,272,907
| Salary | $1,047,431 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $1,740,800 |
| Value of Option Awards | $2,756,847 |
| Non-Equity Incentive Plan Compensation | $722,730 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $5,099 |
| Total | $6,272,907 |
Theravance Biopharma, Inc. disclosed its CEO pay was
25
times its median employee's pay for the fiscal year ending in 2022.
How Do You Compare?
